Emmaus Life Sciences grants CEO Yutaka Niihara warrant to purchase 7.5M shares at $4.50

Emmaus Life Sciences, Inc.

CEO Niihara receives 5-year warrant for 7.5M shares at $4.50, fully vested on grant date.
Two consultants each receive 5-year warrants for 250K shares at $0.50.
Non-employee directors granted options for 100K shares each at $4.50, vesting quarterly over 1 year.
Executives (COO, CFO, others) granted options totaling 850K shares at $4.50 with multi-stage vesting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.